Fenimore Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-914
Closed -$246K 96
2023
Q3
$246K Sell
914
-650
-42% -$162K 0.01% 98
2023
Q2
$347K Hold
1,564
0.01% 91
2023
Q1
$378K Hold
1,564
0.01% 90
2022
Q4
$411K Hold
1,564
0.01% 94
2022
Q3
$353K Hold
1,564
0.01% 98
2022
Q2
$381K Hold
1,564
0.01% 98
2022
Q1
$378K Hold
1,564
0.01% 103
2021
Q4
$352K Hold
1,564
0.01% 105
2021
Q3
$333K Sell
1,564
-123
-7% -$28.3K 0.01% 100
2021
Q2
$411K Sell
1,687
-20
-1% -$4.92K 0.01% 102
2021
Q1
$425K Hold
1,707
0.01% 96
2020
Q4
$392K Sell
1,707
-30
-2% -$6.92K 0.01% 91
2020
Q3
$441K Hold
1,737
0.01% 89
2020
Q2
$410K Hold
1,737
0.01% 91
2020
Q1
$352K Hold
1,737
0.01% 97
2019
Q4
$419K Hold
1,737
0.01% 93
2019
Q3
$336K Hold
1,737
0.01% 104
2019
Q2
$320K Hold
1,737
0.01% 104
2019
Q1
$330K Hold
1,737
0.01% 103
2018
Q4
$338K Hold
1,737
0.01% 101
2018
Q3
$360K Hold
1,737
0.01% 105
2018
Q2
$321K Buy
1,737
+173
+11% +$30.6K 0.01% 105
2018
Q1
$267K Hold
1,564
0.01% 104
2017
Q4
$272K Hold
1,564
0.01% 106
2017
Q3
$292K Buy
1,564
+300
+24% +$53.2K 0.01% 101
2017
Q2
$218K Hold
1,264
0.01% 100
2017
Q1
$207K Buy
+1,264
New +$210K 0.01% 100
2016
Q4
Sell
-1,914
Closed -$319K 98
2016
Q3
$319K Hold
1,914
0.02% 93
2016
Q2
$291K Hold
1,914
0.01% 95
2016
Q1
$287K Hold
1,914
0.01% 95
2015
Q4
$311K Hold
1,914
0.02% 96
2015
Q3
$265K Hold
1,914
0.01% 103
2015
Q2
$294K Hold
1,914
0.02% 102
2015
Q1
$306K Hold
1,914
0.02% 96
2014
Q4
$305K Hold
1,914
0.02% 98
2014
Q3
$269K Hold
1,914
0.01% 95
2014
Q2
$227K Hold
1,914
0.01% 100
2014
Q1
$236K Hold
1,914
0.01% 98
2013
Q4
$218K Hold
1,914
0.01% 98
2013
Q3
$214K Buy
+1,914
New +$208K 0.01% 100

Other funds holding AMGN

Fenimore Asset Management's AMGN Position: Q4 2023 in Review

Fenimore Asset Management sold out of Amgen (AMGN) in Q4 2023, closing a stake of 914 shares — an estimated $246K sold.

Fenimore Asset Management first reported a position in AMGN in Q3 2013 and held it in 40 quarters. The position peaked at $441K in Q3 2020. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Fenimore Asset Management reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Fenimore Asset Management sold 914 Amgen shares in Q4 2023, an estimated $246K.
  • Fenimore Asset Management first reported a position in Amgen in Q3 2013 and held it in 40 quarters.
  • Fenimore Asset Management's Amgen position peaked at $441K in Q3 2020.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Fenimore Asset Management's 13F filing for Q4 2023, filed 23 Jan 2024.